Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone check-ups after colon surgery may cut hospital returns

NCT ID NCT06850688

Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a remote monitoring platform can help patients recover at home after colorectal surgery and avoid being readmitted to the hospital. About 362 adults who had or will have colorectal surgery will be randomly assigned to either 30 days of remote monitoring with connected devices or standard discharge care. Researchers will track hospital readmissions and total days spent in the hospital up to 90 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote monitoring platform (EPOCA Intelligence Information System) with connected devices like oximeters and blood pressure monitors
What this could lead to
If it works, this could reduce hospital readmissions and shorten hospital stays after colorectal surgery, improving recovery at home.
What could go wrong
This is an early-stage study focused on monitoring, not a new treatment. The technology may not reduce readmissions or could be inconvenient for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 362 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Man or woman over 18 years old at the time of the J0 visit, * Patient who underwent surgery less than 28 days ago, or who is scheduled to undergo colorectal surgery not managed as an outpatient procedure at the investigational center, including resection of at least one colonic or rectal segment and/or an anastomosis involving the colon or rectum, * At least one of the following two criteria: * Anticipated early discharge (within 24 hours following laparoscopic surgery without stoma and without diversion, and within 5 days following laparotomy and/or surgery with stoma and/or rectal surgery) for a procedure that is not usually managed as an outpatient surgery in routine practice, * Estimated risk of hospital readmission greater than 10% according to the nomogram of Tevis et al. \[15\], adapted to the postoperative context in digestive surgery (\>120 points according to this score). * Patient affiliated with a health insurance plan, * Patient who has signed the study consent form. Exclusion Criteria: * Discharge to a rehabilitation center requested by the patient, * Condition managed on an outpatient basis in routine practice for this type of patient, * Patient eligible for home hospitalization services, * Suicidal or hetero-aggressive risk in a patient living alone at home * Homeless patient, * Pregnant or breastfeeding women, * Patient under legal guardianship, curatorship, or protected legal status, * Patient already enrolled in an interventional postoperative follow-up study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal surgery Readmission

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    14 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Tours

    RECRUITING

    Tours, France

  • CHU Angers

    RECRUITING

    Angers, France

  • CHU Grenoble

    RECRUITING

    Grenoble, France

  • CHU Nantes

    RECRUITING

    Nantes, France

  • CHU Rennes

    RECRUITING

    Rennes, France

  • CHU Timone - Assistance publique-Hôpitaux de Marseille

    RECRUITING

    Marseille, France

  • CHU Toulouse

    RECRUITING

    Toulouse, France

  • Centre Hospitalier Lyon-Sud

    RECRUITING

    Lyon, France

  • Clinique Mutualiste de l'estuaire

    RECRUITING

    Saint-Nazaire, France

  • Clinique Tivoli- Ducos

    RECRUITING

    Bordeaux, France

  • Hôpital Nord - Assistance publique- Hôpitaux de Marseille

    RECRUITING

    Marseille, France

  • Hôpital Saint Antoine - Assistance publique - Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital de Bicêtre - Assistance Publique Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Institut Paoli Calmettes

    NOT_YET_RECRUITING

    Marseille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.